Revistas & Jornais

Início Revistas & Jornais

Jornal Médico – Julho de 2016

1 2

Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis 29 Julho, 2019
Guselkumab for the treatment of psoriasis – evidence to date. 13 Julho, 2019
More than skin deep: the systemic nature of atopic dermatitis 21 Junho, 2019